Services Mapping Among Older Adults With Hip Fracture (HiFit)

Multicenter Prospective Observational Study in Hip Fracture Among Older Adults

Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention, but this kind of standardized practice in hip fracture care is not yet existed in China. The Blue Book standards will be used as the most contemporary evidence-based guidelines for management of hip fracture.This study is to prospectively examine the barriers and facilitators in the current management of hospital in China by comparing the Blue Book standards.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

2500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China, 100088
        • The George Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have a history of an acute injury that occurred within 21 days, and diagosed by X-ray will be recruited in this study.

Description

Inclusion Criteria:

  • Adults aged 65 years old or over;
  • Hip fracture with X-ray-confirmed femoral neck, trochanteric or sub-trochanteric fracture;
  • Within 21 days of a hip fracture;
  • Willingness to sign informed consent form;

Exclusion Criteria:

  • Patients with pathological fractures;
  • With terminal malignancies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Hip Fracture
Hip Fracture Surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operative administration within 48 hours
Time Frame: One year
The proportion of patients who are operated within 48 hours in the past one year
One year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A&E Admission within 4 hours
Time Frame: One year
The proportion of patients who admit to orthopaedic ward from A&E within 4 hours in the past one year
One year
The Incidence of Pressure Ulcer
Time Frame: One year
The incidence of pressure ulcer in the past one year via nurses provide assessment
One year
The Proportion of Patients Who Receive Geriatrician Assessment
Time Frame: One year
The proportion of patients who receive the assessment of geriatricians in the past one year
One year
The Proportion of Patients Who Receive Osteoporosis Assessment and Treatment
Time Frame: One year
The proportion of patients who receive osteoporosis assessment and treatment the hospital provided in the past one year
One year
The Proportion of Patients Who Receive Specialist Falls Assessment
Time Frame: One year
The proportion of patients who receive specialist falls assessment in the past one year
One year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality Rate in One Month, Four-Month, and One Year
Time Frame: One month, four-month, and one year
The mortality rate in one, four-month, and one year after admission to hospital
One month, four-month, and one year
The Incidence of Complications in One Month, Four-Month, and One year
Time Frame: One month, four-month, and one year
The incidence of complications in one month, four-month and one year after admission to hospital, including pneumonia, deep vein thrombosis, heart disease, etc.
One month, four-month, and one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 14, 2018

Primary Completion (ANTICIPATED)

November 13, 2021

Study Completion (ANTICIPATED)

November 13, 2021

Study Registration Dates

First Submitted

June 8, 2017

First Submitted That Met QC Criteria

June 11, 2017

First Posted (ACTUAL)

June 14, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 5, 2020

Last Update Submitted That Met QC Criteria

February 3, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 0281001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Hip Fracture Surgery

Subscribe